This website is intended for UK healthcare professionals only Log in | Register

Tag Archives: transcatheter aortic valve implantation

August 2018 Br J Cardiol 2018;25:90–1

News from EuroPCR 2018

Christopher Allen

Abstract

Coronary intervention – Trials As the first ever blinded, sham-controlled, percutaneous coronary intervention (PCI) trial, demonstrating a non-statistically significant increase in exercise time at six weeks from PCI over optimal medical therapy (OMT), to say the publication of ORBITA (Percutaneous Coronary Intervention in Stable Angina) last year caused a stir would be quite the understatement. Regardless of your interpretation of the data,1 or ensuing hyperbole,2 unanswered questions certainly remained. Presentation of the previously blinded, invasive physiology data in the opening late-breaking clinical trials session here was therefore

| Full text

April 2017 Br J Cardiol 2017;24:59-60 Online First

News from the British Heart Valve Society

Margaret Loudon

Abstract

A pathologist’s eye view of valve disease started the day with a presentation from Professor Kim Survana (Consultant Pathologist, Sheffield Teaching Hospitals NHS Trust). Covering the range from normality, to degenerative, calcific, rheumatic, congenital and infective pathology, slides of macroscopic and microscopic specimens brought to life what cardiologists see and hear in their daily practice, or as Professor John Chambers (Consultant Cardiologist, St Thomas’s Hospital, London) coined: “the reality of shadows”. Reviewing culture negative endocarditis, Dr John Klein (Consultant Microbiologist, Guy’s and St Thomas’s NHS Foundati

| Full text
Patients with a mechanical mitral valve are potential candidates for TAVI

April 2015 Br J Cardiol 2015;22:(2) doi:10.5837/bjc.2015.015 Online First

Patients with a mechanical mitral valve are potential candidates for TAVI

Katie E O’Sullivan, Eoghan T Hurley, Declan Sugrue, John P Hurley

Abstract

Introduction Figure 1. View at time of implantation demonstrating a newly deployed JenaValveTM in a patient with a Medtronic-Hall disc valve in the mitral position Transcatheter aortic valve implantation (TAVI) has become standard of care for patients with severe aortic stenosis at prohibitive operative risk for surgical aortic valve replacement (SAVR).1 The first randomised-controlled trial of TAVI stipulated the presence of a mitral valve prosthesis as an exclusion criterion for enrolment in the trial.2 The main reason was concern that dysfunction of the mitral valve prosthesis might arise during TAVI valve deployment.3 Further concerns wer

| Full text
News from the British Society for Heart Failure 17th Annual Autumn Meeting

February 2015 Br J Cardiol 2015;22:18 Online First

News from the British Society for Heart Failure 17th Annual Autumn Meeting

Drs Lindsey Tilling; Eleanor Wicks

Abstract

Anaemia was one of several problems chosen for a case-based discussion in a session on common non-cardiac co-morbidities. Dr Callum Chapman (West Middlesex University Hospital) presented the case of an elderly patient with known coeliac disease who had undergone transcatheter aortic valve implantation, which resulted in a paraprosthetic leak and impingement of the mitral valve. Unfortunately despite medical management of the leak she presented to the elderly care service in New York Heart Association (NYHA) Class III heart failure and was extremely oedematous. Blood tests revealed an iron deficiency anaemia and a reduced transferrin saturati

| Full text

September 2014 Br J Cardiol 2014;21:113–14 doi:10.5837/bjc.2014.027

Provision of cardiopulmonary bypass and surgical backup during TAVI: impact on surgical services

Jon R Spiro, Vinod Venugopal, Peter F Ludman, John N Townend, Sagar N Doshi; on behalf of the UK TAVI Steering Group

Abstract

Introduction The provision of cardiopulmonary bypass (CPB) equipment and cardiothoracic (CT) surgical back-up during transcatheter aortic valve implantation (TAVI) has major implications for surgical services. Consensus statements from the Society of Cardiothoracic Surgery (SCTS) and the British Cardiovascular Intervention Society (BCIS) recommend that centres performing TAVI should have “immediate availability of perfusion services in case of the need for emergency bypass”, and that this, together with other criteria, mean that TAVI should only be performed in units currently performing surgical aortic valve replacement. There has, howev

| Full text
News from the American College of Cardiology Scientific Session 2011

June 2011 Br J Cardiol 2011;18:105–8

News from the American College of Cardiology Scientific Session 2011

BJCardio Staff

Abstract

PARTNER: transcatheter valves just as good as surgery for high risk aortic stenosis Transcatheter aortic valve implantation (TAVI) is just as effective at reducing mortality as surgery for severe aortic stenosis in elderly patients whose age and overall health posed high risks for conventional surgery, according to the results of the PARTNER (Placement of AoRTic TraNscathetER Valve trial). However, stroke rates were higher in the trancatheter group. The transcatheter approach involves delivering a bioprosthetic valve to its target location with a catheter using either transfemoral access or trans-apical access (through the ribs) if peripheral

| Full text
Close

You are not logged in

You need to be a member to print this page.
Find out more about our membership benefits

Register Now Already a member? Login now
Close

You are not logged in

You need to be a member to download PDF's.
Find out more about our membership benefits

Register Now Already a member? Login now